Sports Medicine

, Volume 26, Issue 4, pp 207–216 | Cite as

Iron Supplementation in Athletes

Current Recommendations
  • Peter NielsenEmail author
  • Detlef Nachtigall
Leading Article


There is still debate in the literature on whether or not endurance athletes tend to have low iron stores. In this article, we propose that endurance athletes really are at risk of becoming iron deficient due to an imbalance between absorption of dietary iron and exercise-induced iron loss. The purpose of this article is to present a critical review of the literature on iron supplementation in sport. The effect of iron deficiency on performance, its diagnosis and suggestions for treatment are also discussed.

Studies of the nutritional status of athletes in various disciplines have shown that male, but not female, athletes clearly achieve the recommended dietary intake of iron (10 to 15 mg/day). This reflects the situation in the general population, with menstruating women being the main risk group for mild iron deficiency, even in developed countries. Whereas the benefit of iron supplementation in athletes with iron deficiency anaemia is well established, this is apparently not true for non-anaemic athletes who have exhausted iron stores alone (prelatent iron deficiency); most of the studies in the literature show no significant changes due to supplementation in the physical capacity of athletes with prelatent iron deficiency. However, the treatment protocols used in some of these studies do not meet the general recommendations for the optimal clinical management of iron deficiency, that is, with respect to adequate daily dosage, mode of administration and treatment period. For future studies, we recommend a prolonged treatment period (≥3 months) with standardised conditions of administration (use of a pharmaceutical iron preparation with known high bioavailability and a dosage of ferrous (Fe++) iron 100 mg/day, taken on an empty stomach).

Currently, decisions regarding iron supplementation are best made on the basis of taking care of individual athletes. We believe that there are sufficient arguments to support controlled iron supplementation in all athletes with low serum ferritin levels. Firstly, the development of iron deficiency is prevented. Secondly, the nonspecific upregulation of intestinal metal ion absorption is reverted to normal, thus limiting the hyperabsorption of potentially toxic lead and cadmium even in individuals with mild iron deficiency.


Adis International Limited Ferritin Iron Deficiency Serum Ferritin Iron Supplementation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Balaban EP. Sports anemia. Clin Sports Med 1992; 11 (2): 313–25PubMedGoogle Scholar
  2. 2.
    Weight LM, Klein M, Noakes TD, et al. Sports anemia: a real or apparent phenomenon in endurance-trained athletes?. Int J Sports Med 1992; 13: 344–7PubMedCrossRefGoogle Scholar
  3. 3.
    Newhouse IJ, Clement DB. Iron status in athletes: an update. Sports Med 1988; 5: 337–52PubMedCrossRefGoogle Scholar
  4. 4.
    Haymes EM, Lamanca JL. Iron loss in runners during exercise: implications and recommendations. Sports Med 1989; 7: 277–85PubMedCrossRefGoogle Scholar
  5. 5.
    Smith JA. Exercise, training and red blood cell turnover. Sports Med 1995; 19 (1): 9–31PubMedCrossRefGoogle Scholar
  6. 6.
    Burke LM, Read RSD. Dietary supplements in sport. Sports Med 1993; 15: 43–65PubMedCrossRefGoogle Scholar
  7. 7.
    Fogelholm M. Indicators of vitamin and mineral status in athletes blood: a review. Int J Sport Nutr 1995; 5: 267–84PubMedGoogle Scholar
  8. 8.
    Baynes RD. Iron deficiency. In. Brock JH, Halliday JW, Pippard MJ, et al., editors. Iron metabolism in health and disease. London: Saunders, 1994; 189–226Google Scholar
  9. 9.
    Heinrich HC. Intestinal iron absorption in man: methods of measurements, dose relationship, diagnostic and therapeutic applications. In. Hallberg L, Harwerth HG, Vannotti A, editors. Iron deficiency. London/New York: Academic Press, 1970: 213–94Google Scholar
  10. 10.
    Heinrich HC. Falsely low normal values for serum ferritin?. Clin Chem 1981; 27: 768PubMedGoogle Scholar
  11. 11.
    Nachtigall D, Nielsen P, Fischer R, et al. Iron deficiency in distance runners: a reinvestigation using 59Fe-labelling and non-invasive liver iron quantification. Int J Sports Med 1996; 17: 473–9PubMedCrossRefGoogle Scholar
  12. 12.
    Ehn L, Carlmark B, Höglund S. Iron status in athletes involved in intense physical activity. Med Sci Sports Exerc 1980; 12 (1): 61–4PubMedGoogle Scholar
  13. 13.
    Magnusson B, Hallberg L, Rossander L, et al. Iron metabolism and sports anemia. Acta Med Scand 1984; 216: 157–64PubMedCrossRefGoogle Scholar
  14. 14.
    Pattini A, Schena F. Effects of training and iron supplementation on iron status of cross-country skiers. J Sports Med Phys Fitness 1990; 30 (4): 347–53PubMedGoogle Scholar
  15. 15.
    Herbert V. Recommended dietary intakes (RDI) of iron in humans. Am J Clin Nutr 1987; 45: 679–86PubMedGoogle Scholar
  16. 16.
    van Erp-Baart AMJ, Saris WMH, Binkhorst RA, et al. Nationwide survey on nutritional habits in elite athletes: part II: mineral and vitamin intake. Int J Sports Med 1989; 10 Suppl. 1: S11–6PubMedCrossRefGoogle Scholar
  17. 17.
    Weight LM, Jacobs P, Noakes TD. Dietary iron deficiency and sports anemia. Br J Nutr 1992; 68: 253–60PubMedCrossRefGoogle Scholar
  18. 18.
    Nuviala RJ, Castillo MC, Lapieza MG, et al. Iron nutritional status in female karatekas, handball and basketball players, and runners. Physiol Behav 1996; 59 (3): 449–53PubMedCrossRefGoogle Scholar
  19. 19.
    Lyle RM, Weaver CM, Sedlock DA, et al. Iron status in exercising women: the effect of oral iron therapy vs increased consumption of muscle foods. Am J Clin Nutr 1992; 56: 1049–55PubMedGoogle Scholar
  20. 20.
    Rowland TW, Deisroth MB, Green GM, et al. The effect of iron therapy on the exercise capacity of nonanemic iron-deficient adolescent runners. Am J Dis Child 1988; 142: 165–9PubMedGoogle Scholar
  21. 21.
    Magazanik A, Weinstein Y, Abarbanel J, et al. Effect of an iron supplement on body iron status and aerobic capacity of young training women. Eur J Appl Physiol 1991; 62: 317–23CrossRefGoogle Scholar
  22. 22.
    LaManca JJ, Haymes EM. Effects of iron repletion on VO2max, endurance, and blood lactate in women. Med Sci Sports Exerc 1993; 25: 1386–92PubMedGoogle Scholar
  23. 23.
    Risser WL, Lee EJ, Poindexter HBW, et al. Iron deficiency in female athletes: its prevalence and impact on performance. Med Sci Sports Exerc 1988; 20: 116–21PubMedCrossRefGoogle Scholar
  24. 24.
    Powell PD, Tucker A. Iron supplementation and running performance in female cross-country runners. Int J Sports Med 1991; 12: 462–7PubMedCrossRefGoogle Scholar
  25. 25.
    Fogelholm M, Jaakkola L, Lampisjaervi T. Effects of iron supplementation in female athletes with low serum ferritin concentration. Int J Sports Med 1992; 13: 158–62PubMedCrossRefGoogle Scholar
  26. 26.
    Klingshirn LA, Pate RR, Bourque SP, et al. Effect of iron supplementation on endurance capacity in iron-depleted female runners. Med Sci Sports Exerc 1992; 24: 819–24PubMedGoogle Scholar
  27. 27.
    Dressendorfer RH, Keen CL, Wade CE, et al. Development of runner’s anemia during a 20-day road race: effect of iron supplements. Int J Sports Med 1991; 12: 332–6PubMedCrossRefGoogle Scholar
  28. 28.
    Newhouse IJ, Clement DB, Taunton JE, et al. The effects of prelatent/latent iron deficiency on physical work capacity. Med Sci Sports Exerc 1989; 21: 263–8PubMedGoogle Scholar
  29. 29.
    Karamizrak SO, Islegen C, Varol SR, et al. Evaluation of iron metabolism indices and their relation with physical work capacity in athletes. Br J Sports Med 1996; 30: 15–9PubMedCrossRefGoogle Scholar
  30. 30.
    Matter M, Stittfall T, Graves J, et al. The effect of iron and folate therapy on maximal exercise performance in female marathon runners with iron and folate deficiency. Clin Sci 1987; 72: 415–22PubMedGoogle Scholar
  31. 31.
    Gardner GW, Edgerton VR, Barnard RJ, et al. Cardiorespiratory, hematological and physical performance responses of anemic subjects to iron treatment. Am J Clin Nutr 1975; 28: 982–8PubMedGoogle Scholar
  32. 32.
    Schoene RB, Escourrou P, Robertson HT, et al. Iron repletion decreases maximal excercise lactate concentrations in female athletes with minimal iron-deficiency anemia. J Lab Clin Med 1983; 102: 306–12PubMedGoogle Scholar
  33. 33.
    Walters GO, Miller FM, Woorwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 1973; 26: 770–2PubMedCrossRefGoogle Scholar
  34. 34.
    Nielsen P, Gabbe EE, Fischer R, et al. Bioavailability of iron from oral ferric polymaltose in humans. Arzneimittel Forschung 1994; 44: 743–8PubMedGoogle Scholar
  35. 35.
    Heinrich HC, Gabbe EE, Kugler G, et al. Iron absorption from ingested pork, hog-liver and haemoglobin in subjects with normal and depleted iron stores: studies on dietary prophylaxis and therapy. Klin Wochenschr 1971; 49: 819–25PubMedCrossRefGoogle Scholar
  36. 36.
    Sölvell L. Oral iron therapy — side effects. In. Hallberg L, Harwerth HG, Vannotti A, editors. Iron deficiency. London/New York: Academic Press, 1970: 573–83Google Scholar
  37. 37.
    Hooper SL, Mackinnon LT. Monitoring overtraining in athletes: recommendations. Sports Med 1995; 20 (5): 321–7PubMedCrossRefGoogle Scholar
  38. 38.
    Dressendorfer RH, Wade CE, Amsterdam EA. Development of pseudoanemia in marathon runners during a 20-day road race. JAMA 1981; 246: 1215–8PubMedCrossRefGoogle Scholar
  39. 39.
    Magnusson B, Björn-Rasmussen E, Hallberg L, et al. Iron absorption in relation to iron status: model proposed to express results to food iron absorption measurements. Scand J Haematol 1981; 27: 201–8PubMedCrossRefGoogle Scholar
  40. 40.
    Watson WS, Morrison J, Bethel MI. Food iron and lead absorption in humans. Am J Clin Nutr 1986; 44: 248–56PubMedGoogle Scholar
  41. 41.
    Salonen JT, Nyyssnen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86: 803–11PubMedCrossRefGoogle Scholar
  42. 42.
    Stevens RG, Jones DY, Micozzi MS, et al. Body iron stores and the risk of cancer. N Engl J Med 1988; 319: 1047–52PubMedCrossRefGoogle Scholar
  43. 43.
    Baer DM, Tekawa IS, Hurley LB. Iron stores are not associated with acute myocardial infarction. Circulation 1994; 89: 2915–8PubMedCrossRefGoogle Scholar
  44. 44.
    Niederau C, Fischer R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis. N Engl J Med 1986; 313: 1256–62CrossRefGoogle Scholar
  45. 45.
    Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 1996; 13: 399–408PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited. All rights reserved 1998

Authors and Affiliations

  1. 1.Abteilung Medizinische Biochemie, Institut für Physiologische ChemieUniversitäts-Krankenhaus EppendorfHamburgGermany

Personalised recommendations